ALDX - Aldeyra The Stock Analysis | Stock Taper

SCREENER COMPARE ANY 2 STOCKS

ALDX

ALDEYRA THE

NASDAQ

$1.49

▼ DOWN 3.57% (-0.06)

KEY STATISTICS

Market Cap$89.58 M

52w High$5.93

52w Low$1.07

Dividend Yield—

Frequency—

P/E-3.81

Volume547.97K

Shares Out.60.32M

COMPANY

LEADERSHIP

Todd C. Brady

CHIEF EXECUTIVE

Todd C. Brady

COMPENSATION 2026

Salary$700,000

Stock Awards$0

Incentive Plan Pay$189,000

All Other Comp.$14,000

Total$4,704,179

ABOUT

SECTOR

Healthcare

WENT PUBLIC

May 2, 2014

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

6

PRICE TARGET

Target High$12.00

Target Low$7.00

Target Median$10.00

Target Consensus$9.67

UPCOMING EARNINGS

DateNov 4, 2026

DayWednesday

Rev. Est.$2.50M

NOV

4

WED

PRICE

$1.49 ▼ DOWN 3.57% (−$0.06)

About Aldeyra The

https://www.aldeyra.com ↗

Aldeyra Therapeutics is a biotech firm developing immune-modulating medicines like reproxalap for ocular and systemic diseases, with multiple products in clinical trials for conditions such as dry eye, psoriasis, asthma, COVID-19, and retinal diso...

INDUSTRY

Biotechnology

A PRODUCT ALDEYRA THE IS KNOWN FOR

Reproxalap

Reproxalap

Reproxalap, Aldeyra's lead investigational small-molecule targeting RASP, is being developed for dry eye disease and allergic conjunctivitis, with a New Drug Application under review by the FDA.

COMPETITORS

COMPETITOR

ETFS HOLDING THIS STOCK

ETFS HOLDING

16

LISTED HERE

4

RANKED BY POSITION SIZE

0.02% · 190.0K

0.01% · 104.9K

INSTITUTIONAL OWNERSHIP

SHARES OWNED

56.79%

HOLDERS

187

TOP 12 OF 187 · RANKED BY POSITION SIZE

Knoll Capital Management, LLC

5.5M sh · $9.25M

Perceptive Advisors LLC

5.2M sh · $27.26M

Blackrock, Inc.

3.9M sh · $19.94M

Vanguard Group Inc

3.7M sh · $19.16M

3.6M sh · $11.99M

Aqr Capital Management LLC

2.8M sh · $4.78M

Kingdon Capital Management, L.L.C.

2.2M sh · $3.64M

Ardsley Advisory Partners LP

1.9M sh · $9.92M

D. E. Shaw & Co., Inc.

1.6M sh · $8.29M

683 Capital Management, LLC

1.5M sh · $7.93M

Geode Capital Management, LLC

1.3M sh · $2.12M

State Street Corp

1.1M sh · $1.9M

RATINGS SNAPSHOT

Overall rating: C+

Discounted Cash Flow4

Return On Equity1

Return On Assets1

Debt To Equity4

Price To Earnings1

Price To Book2

Overall Score2

INSIDER TRADES

★

DIRECTOR

DOUGLAS RICHARD

Purchase · 2.3K shares

2026-06-09

★

DIRECTOR

Phillips Gary M.

Purchase · 6.6K shares

2026-06-09

★

DIRECTOR

Walker Neal

Purchase · 3.3K shares

2026-06-09

★

DIRECTOR

DOUGLAS RICHARD

Purchase · 19.9K shares

2026-06-09

MOST RECENT ANALYST GRADES

GRADE SUMMARY

NEUTRAL 1

BUY 1

2 GRADES IN THE LAST 12 MONTHS

HC Wainwright & Co. NEUTRAL

SECTORS PEERS

PEER	PRICE
ANRO	$35.13	COMPARE
CADL	$13.07	COMPARE
CTNM	$17.05	COMPARE
SLN	$13.42	COMPARE
KYTX	$8.37	COMPARE
CLLS	$3.40	COMPARE
AMRN	$13.97	COMPARE
ACIU	$2.65	COMPARE